Amphion Innovations (AMP)

 

Latest News

Amphion Innovations cuts Motif Bio stake to repay debt

Amphion Innovations said it had sold shares in partner company Motif Bio to a US institutional investor for $3.7m and wo...

Motif Bio notes statement from Amphion Innovations

RNS Number: 9502O Motif Bio PLC 23 May 2018 Motif Bio plc ("Motif Bio" or the "Company") Motif Bio notes statement from Amphion Innovations Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, notes the announcement made today via RNS by Amphion Innovations plc ("Amphion"...

Sale of Partner Company Shares

RNS Number: 9386O Amphion Innovations PLC 23 May 2018 Amphion Innovations plc ("Amphion" or "the Company") Sale of Partner Company Shares London and New York: Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that 8,896,034 shares in Partner Company, Motif Bio plc ("Motif"), have b...

Directorate Change

RNS Number: 5404L Amphion Innovations PLC 20 April 2018 Amphion Innovations plc ("Amphion" or "the Company") Directorate Change London and New York, 20 April 2018 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that Miroslaw Izienicki and Richard Mansell-Jones have resigned as N...

All News

DateHeadlineSource
22-12-17Amphion agrees loan restructuringStockMarketWire
22-12-17Comment on Polarean Fund RaiseRNS
22-12-17Restructure of Loan and Additional DrawdownRNS
05-12-17Issue of SharesRNS
01-12-17These five AIM firms could own the tech stars of tomorrowInteractive Investor
23-11-17Amphion update on Polarean's proposed IPOStockMarketWire
23-11-17Further Update on Polarean Imaging LimitedRNS
10-11-17Amphion update on Polarean Imaging StockMarketWire
10-11-17Update on Polarean Imaging LimitedRNS
02-11-17DataTern case against MicroStrategy dismissed StockMarketWire
02-11-17Order Dismissing DataTern CaseRNS
11-10-17Related Party TransactionRNS
05-10-17Amphion partner releases positive clinical resultsStockMarketWire
05-10-17Partner Company releases positive clinical resultsRNS
29-09-17Amphion revenues rise StockMarketWire
29-09-17Half-year ReportRNS
25-09-17Holding(s) in CompanyRNS
25-09-17Sale of Partner Company SharesRNS
30-08-17Amphion reduces stake in Motif BioStockMarketWire
30-08-17Holding(s) in CompanyRNS
30-08-17Sale of partner company sharesRNS
01-08-17AGM StatementRNS
28-06-17FTSE falls on mixed bag led by utilities, oil majorsStockMarketWire
28-06-17Final ResultsRNS
31-05-17Amphion partner company agrees merger StockMarketWire
31-05-17Partner Company m2m Imaging merger updateRNS
23-05-17Amphion draws down additional $1.5mStockMarketWire
22-05-17Additional Draw Down on Loan FacilityRNS
07-02-17Amphion draws down additional $500,000StockMarketWire
07-02-17Additional Draw Down on Loan FacilityRNS
01-02-17Holding(s) in CompanyRNS
30-12-16Holding(s) in CompanyRNS
16-12-16Director/PDMR ShareholdingRNS
09-12-16Director/PDMR ShareholdingRNS
24-11-16Holding(s) in CompanyRNS
08-09-16Amphion re-negotiates terms of Motif CPNStockMarketWire
08-09-16Re-negotiated terms of Motif CPNRNS
07-09-16Amphion NAV up StockMarketWire
07-09-16Interim Results for the six months to 30 June 2016RNS
22-08-16Additional Draw Down on Loan FacilityRNS

RSS feeds

  • Editorial news feed for LSE:AMP Editorial
  • Regulatory news feed for LSE:AMP Regulatory